⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGN News
Organon & Co.
Form 8-K
sec.gov
ENTX
OGN
MRK
Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors
globenewswire.com
OGN
ENTX
MRK
Germany Digital Health Market Size, Share, Trends, and Forecast, 2026-2033 | DiGA Reimbursement, AI, mHealth, and Telehealth Unlock Growth Opportunities
globenewswire.com
GOOGL
AAPL
CSCO
MRK
MSI
QCOM
GEHC
ABT
SNPS
ADI
NXPI
INTC
MU
AMAT
KLAC
LRCX
WDC
NVDA
AMD
MRVL
ON
STM
MCHP
TXN
ADBE
IBM
HPQ
DELL
MSFT
AMZN
ORCL
SAP
CRM
VRSN
CTAS
VRSK
NOW
FIS
PAYX
ADP
WDAY
ACN
CPSS
MCK
ALGN
EXPE
CHKP
CDNS
ASML
AIRS
OGN
VOD
CMG
CGEN
United Kingdom Reversible Contraceptive Devices (IUDs, Hormonal Implants & Diaphragms) Market Outlook to 2033 | Demand Trends Reveal Strategic Growth Opportunities
globenewswire.com
OGN
EU5 Reversible Contraceptive Devices Market Outlook to 2033: IUDs, Hormonal Implants and Diaphragms
globenewswire.com
OGN
China Reversible Contraceptive Devices Market Outlook to 2033 - IUDs, Hormonal Implants, and Diaphragms | Growth Opportunities, Pricing Trends, and Competitive Strategy
globenewswire.com
OGN
Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA ®, a Hormone-Free Intrauterine Device
businesswire.com
OGN
National Can-RISE Study to Help Close Critical Gaps in Menopause Research
globenewswire.com
OGN
L’étude Can-RISE nationale aide à combler les lacunes en recherche sur la ménopause
globenewswire.com
OGN
Organon Announces Quarterly Dividend
businesswire.com
OGN